"Unnamed: 0","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-2024101","R-HSA-2024101","CS/DS degradation","2/25","14/10891",0.000452644839133498,0.0445725798824088,0.0330469470981704,"IDUA/BCAN",2
"R-HSA-9660826","R-HSA-9660826","Purinergic signaling in leishmaniasis infection","2/25","26/10891",0.00158953347736718,0.0445725798824088,0.0330469470981704,"NT5E/IL18",2
"R-HSA-9664424","R-HSA-9664424","Cell recruitment (pro-inflammatory response)","2/25","26/10891",0.00158953347736718,0.0445725798824088,0.0330469470981704,"NT5E/IL18",2
"R-HSA-445095","R-HSA-445095","Interaction between L1 and Ankyrins","2/25","31/10891",0.00225833315444511,0.0445725798824088,0.0330469470981704,"SCN3A/SCN2B",2
"R-HSA-373760","R-HSA-373760","L1CAM interactions","3/25","119/10891",0.00245464499704048,0.0445725798824088,0.0330469470981704,"EZR/SCN3A/SCN2B",3
"R-HSA-9658195","R-HSA-9658195","Leishmania infection","4/25","254/10891",0.00248441735550401,0.0445725798824088,0.0330469470981704,"GGT5/NT5E/IL18/SCT",4
"R-HSA-5576892","R-HSA-5576892","Phase 0 - rapid depolarisation","2/25","34/10891",0.00271311355805967,0.0445725798824088,0.0330469470981704,"SCN3A/SCN2B",2
